New York State Common Retirement Fund’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

New York State Common Retirement Fund’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,215	Closed	-$59K	–	3344
2019 Q1	$59K	Hold	2,215	–	–	﹤0.01%	3051
2018 Q4	$50K	Hold	2,215	–	–	﹤0.01%	3091
2018 Q3	$122K	Hold	2,215	–	–	﹤0.01%	3008
2018 Q2	$158K	Hold	2,215	–	–	﹤0.01%	2984
2018 Q1	$136K	Hold	2,215	–	–	﹤0.01%	2874
2017 Q4	$279K	Buy	2,215 +565	+34%	+$72.4K	﹤0.01%	2615
2017 Q3	$226K	Hold	1,650	–	–	﹤0.01%	2715
2017 Q2	$235K	Hold	1,650	–	–	﹤0.01%	2769
2017 Q1	$303K	Hold	1,650	–	–	﹤0.01%	2617
2016 Q4	$133K	Hold	1,650	–	–	﹤0.01%	2910
2016 Q3	$126K	Hold	1,650	–	–	﹤0.01%	2928
2016 Q2	$142K	Hold	1,650	–	–	﹤0.01%	2877
2016 Q1	$153K	Hold	1,650	–	–	﹤0.01%	2790
2015 Q4	$331K	Hold	1,650	–	–	﹤0.01%	2507
2015 Q3	$246K	Sell	1,650 -425	-20%	-$312K	﹤0.01%	2677
2015 Q2	$1.97M	Buy	2,075 +1,772	+585%	+$1.45M	﹤0.01%	1861
2015 Q1	$222K	Buy	+303	New	+$228K	﹤0.01%	2145

Other funds holding TTPH

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

New York State Common Retirement Fund's TTPH Position: Q2 2019 in Review

New York State Common Retirement Fund sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2019, closing a stake of 2,215 shares — an estimated $59K sold.

New York State Common Retirement Fund first reported a position in TTPH in Q1 2015 and held it in 17 quarters. The position peaked at $1.97M in Q2 2015. 66 funds tracked by Wall St. Rank hold TTPH as of Q2 2019.

New York State Common Retirement Fund reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
New York State Common Retirement Fund sold 2,215 Tetraphase Pharmaceuticals, Inc. shares in Q2 2019, an estimated $59K.
New York State Common Retirement Fund first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 17 quarters.
New York State Common Retirement Fund's Tetraphase Pharmaceuticals, Inc. position peaked at $1.97M in Q2 2015.
66 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2019.

Based on New York State Common Retirement Fund's 13F filing for Q2 2019, filed 9 Aug 2019.